Retrospective cohort study evaluates gastrocnemius myocutaneous flap effectiveness in soft-tissue defect reconstruction, suggesting excellent functional and esthetic outcomes.
Background: Reconstructing soft-tissue defects in the proximal, middle thirds of the leg and knee presents a significant challenge due to the pretibial bone’s subcutaneous location and limited local tissue laxity, respectively. These injuries often result from high-energy trauma or oncological resections, frequently leaving critical structures like bone, tendons, or hardware exposed. Gastrocnemius myocutaneous (GMC) flap remains an important option to resurface such defects. Aims and Objectives: (1) The aim of the study was to study the versatility of GMC flap in resurfacing defects around knee, proximal, and mid-third of leg. (2) To know its functional and esthetic outcome. Materials and Methods: This is a retrospective cohort study conducted from 2022 to 2025 on 13 patients with soft-tissue defects requiring flap coverage over the knee, upper, and middle third leg defects. The wounds were resurfaced with GMC flap, and its functional and esthetic outcomes were assessed. Results: All 13 flaps survived completely with complications such as marginal skin necrosis and wound infection noted in 3 flaps, which were managed conservatively. The flap size averaged between 10 × 4 cm and 20 × 7 cm. At final follow-up, patients demonstrated satisfactory limb function and acceptable cosmetic outcome. Conclusion: GMC flap provides to be an excellent option for coverage of knee, upper, and middle third leg defects with very minimal donor site morbidity. This study reinforces its role as a first-line reconstructive choice for such large defects with good functional and esthetic outcome.
No takes yet. Share an insight, caveat, or question.
de et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: